HbA1c ReductionExercise therapy

Clinical evidence dossier

Exercise therapy

HbA1c

Evidence signal

Authoritative evidence signal

strong

This is an authoritative evidence signal supplied by Clinical Reference. It is not a formal clinical grade, treatment recommendation, or pooled effect estimate.

Evidence snapshot

Authoritative support records
8
Supporting studies available for review
8
Randomized trials
7
Reported effects
9

Clinical conclusion

Exercise therapy shows a moderate positive evidence signal for improving HbA1c across the studied comparisons.

The conclusion and evidence-signal classification are distinct authoritative fields and are reproduced as published.

Observed effects

Observed study estimates; not a pooled treatment effect.

Change from baseline

Absolute change

-1.56 to -0.57 %

4 eligible estimates12–12 weeksObserved median: -1.3399999999999999 %

Between-group effect

Absolute change

-0.5 to -0.5 %

1 eligible estimates8–8 weeksObserved median: -0.5 %

Adjusted Model

Mean difference

-0.89 to -0.89 %

1 eligible estimates26–26 weeksObserved median: -0.89 %

Between-group effect

Mean difference

-0.72 to -0.46 %

2 eligible estimates12–12 weeksObserved median: -0.59 %

Evidence composition

Non-randomized studies
1
Other designs
0
Unresolved designs
0
Magnitude-eligible effects
8

Consistency

Authoritative consistency classification

consistent

Positive
6
No effect
2
Mixed
0
Negative
0

Population and applicability

Structured population data were available for 8 of 8 supporting studies. Diabetes type was heterogeneous: 4 studies with type 2 diabetes, 1 studies with type 1 diabetes. Age groups were heterogeneous: 4 studies with adult participants, 1 studies with youth participants.

This population information refers to the materialized supporting studies available for review. Omitted support records remain part of the authoritative support accounting and are available through the audit experience.

View reported population descriptions

These descriptions are reported across the supporting studies; they are not a single synthesized population.

  • Adults newly diagnosed with type 2 diabetes.
  • Individuals seeking dietary interventions for glycemic control.
  • Adults aged 18-65 with prediabetes.
  • Individuals seeking to improve glycemic control through lifestyle changes.
  • Obese adults aged 18-65 with type 2 diabetes.
  • Individuals seeking alternative exercise modalities.
  • Children diagnosed with Type 1 diabetes.
  • Participants engaging in regular physical activity.
  • Adults with multimorbidity, including chronic conditions such as hypertension and diabetes.
  • Individuals seeking non-pharmacological interventions to manage blood pressure.
  • Individuals newly diagnosed with AGT.
  • Patients in Ghana seeking lifestyle interventions for diabetes management.

Limitations

  • 2 supporting studies do not have a displayable topic-matched quantitative effect.
  • Evidence uses heterogeneous comparison contexts: active_comparator, placebo, usual_care.
  • 1 supporting study has high, serious, critical, unclear, or unavailable risk-of-bias information.
  • 5 of 8 studies with duration data have follow-up of 12 weeks or less.
  • 1 study contains conflicting p-value and significance fields; those significance claims are suppressed.

Supporting evidence

Inspect the authoritative studies and omitted support records for this dossier.

View supporting evidence